The results showed that GPC-1 mRNA level was significantly (P < 0.05) elevated in the HCC samples compared with the normal group (normal n = 50, tumor n = 371), and GPC-1 showed significantly higher mRNA levels in stage 3, and there is a potential increase as the cancer progresses (Fig. 6A). The gene discussed is GPC1; the disease is cancer.